News and Updates

What is the pipeline? Every new medical device, therapy, treatment, and drug—including those for type 1 diabetes (T1D)—goes through the drug development pipeline. Getting a new therapy or device from the earliest stages of research eventually into the hands of people with T1D is a complicated process. Science takes time (from years to decades!), money […]

Analysis compiled by Avalere Health and supported by Breakthrough T1D (formerly JDRF) finds that research funded by the Special Diabetes Program (SDP) has yielded more than $50 billion in federal healthcare savings.  Created by Congress in 1997 and administered by the National Institutes of Health (NIH), the SDP provides federal funding to support research to prevent, treat, and […]

Breakthrough T1D headed to Washington D.C. where advocates held nearly 500 meetings with Members of Congress on behalf of the T1D community.

Breakthrough T1D Chief Global Advocacy Officer Lynn Starr discusses how type 1 diabetes advocacy drives our mission progress forward...faster.

With the support of our grassroots advocates, our work helps advance treatments, influence policy, and improve access to care for those worldwide who need it.

Our Advocates traveled to D.C. to reintroduce our organization and champion legislation and policy for the T1D community.

Breakthrough T1D advocate Natalie Stanback knows type 1 diabetes and knows how to get things done on Capitol Hill. She encourages more women to get involved in advocacy.

Super Bowl Champion is key in helping Breakthrough T1D “move the chains” toward the T1D end zone

Delegates with type 1 diabetes at Breakthrough T1D 2023 Children's Congress fought for the special diabetes program and insulin affordability.

JDRF’s Chief Mission Strategy Officer will leave behind quite a legacy once she steps down from her role at Breakthrough T1D at the end of March 2023.